Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |